Previous 10 | Next 10 |
2023-05-15 19:14:12 ET ReShape Lifesciences Inc. (RSLS) Q1 2023 Earnings Conference Call May 15, 2023, 04:30 PM ET Company Participants Michael Miller - Rx Communications, IR Paul Hickey - President and CEO Tom Stankovich - CFO Conference Call Participants ...
Achieved Continued Improvement in Operational Effectiveness With First Quarter 2023 Operating Expenses Down 42.9% Compared to the First Quarter of 2022 Executing a Plan For Growth and Profitability With a Balance Sheet Bolstered By Approximately $12.7 Million Raised in 2023 Conf...
SAN CLEMENTE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the first quarter ended March 31, 2023, includin...
2023-04-29 13:12:02 ET ReShape Lifesciences Inc. (RSLS) Q4 2022 Earnings Conference Call April 25, 2023 4:30 PM ET Company Participants Michael Miller - Investor Relations Paul Hickey - President & Chief Executive Officer Thomas Stankovich - Chief Financial O...
SAN CLEMENTE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will present data on its proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN...
2023-04-25 16:54:28 ET ReShape Lifesciences press release ( NASDAQ: RSLS ): FY Revenue of $11.24M (-17.9% Y/Y) misses by $2.24M . Net loss of $46.21M For further details see: ReShape Lifesciences reports FY results
Continued Sequential Quarterly Growth in the U.S. With Q4 Revenues of $2.7 Million Improved Operational Effectiveness With Second Half 2022 Operating Expenses Down 27.9% Compared to the First Half of 2022, A $5.1 Million Reduction Executing A Plan For Profitability With A Balanc...
2023-04-20 09:35:28 ET ReShape Lifesciences ( NASDAQ: RSLS ) shares dipped 9% on Thursday after the health solutions company priced an offering to raise $2.5M in gross proceeds. The firm entered into a securities purchase agreement with a single institutional investor ...
SAN CLEMENTE, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchas...
2023-04-12 10:03:10 ET Gainers: Altamira Therapeutics ( CYTO ) +74% . Arrowhead Pharmaceuticals ( ARWR ) +11% . Procaps Group ( PROC ) +11% . Tempest Therapeutics ( TPST ) +11% . Meihua International Medical Technologies ( MHUA )...
News, Short Squeeze, Breakout and More Instantly...
ReShape Lifesciences Inc. Company Name:
RSLS Stock Symbol:
OTCMKTS Market:
ReShape Lifesciences Inc. Website:
2024-07-10 06:20:00 ET 3 Key Tips to Investing in Biotech Penny Stocks in 2024 Investing in biotech penny stocks offers an exciting opportunity to capitalize on the rapid advancements in medical and healthcare technologies. These small-cap stocks often belong to companies that are d...
CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, announced today that it has signed a merger agreement with ReShape Lifesciences (Na...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) fell 9.3% to $0.2448 on volume of 58,139,351 shares NVIDIA Corporation (NVDA) rose 2.9% to $131.9 on volume of 38,975,630 shares Soligenix Inc. (SNGX) rose 189.2% to $5.784 on volume of 36,915,609...